• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病的遗传学。

Genetics of dilated cardiomyopathy.

机构信息

Molecular Cardiology Division, Victor Chang Cardiac Research Institute, 405 Liverpool Street, Darlinghurst, NSW 2010, Australia.

出版信息

Heart Fail Clin. 2010 Apr;6(2):129-40. doi: 10.1016/j.hfc.2009.11.003.

DOI:10.1016/j.hfc.2009.11.003
PMID:20347783
Abstract

Dilated cardiomyopathy (DCM) is a myocardial disorder defined by ventricular chamber enlargement and systolic dysfunction. DCM can result in progressive heart failure, arrhythmias, thromboembolism, and premature death, and contributes significantly to health care costs. In many cases, DCM results from acquired factors that affect cardiomyocyte function or survival. Inherited genetic variants are also now recognized to have an important role in the etiology of DCM. Despite substantial progress over the past decade, our understanding of familial DCM remains incomplete. Current concepts of the molecular pathogenesis, clinical presentation, natural history, and management of familial DCM are outlined in this review.

摘要

扩张型心肌病(DCM)是一种以心室腔扩大和收缩功能障碍为特征的心肌疾病。DCM 可导致进行性心力衰竭、心律失常、血栓栓塞和过早死亡,并显著增加医疗保健成本。在许多情况下,DCM 是由影响心肌细胞功能或存活的获得性因素引起的。遗传性遗传变异现在也被认为在 DCM 的病因学中起重要作用。尽管在过去十年中取得了重大进展,但我们对家族性 DCM 的理解仍不完整。本文综述了家族性 DCM 的分子发病机制、临床表现、自然史和治疗的新概念。

相似文献

1
Genetics of dilated cardiomyopathy.扩张型心肌病的遗传学。
Heart Fail Clin. 2010 Apr;6(2):129-40. doi: 10.1016/j.hfc.2009.11.003.
2
[Familial dilated cardiomyopathy].[家族性扩张型心肌病]
Herz. 2005 Sep;30(6):529-34. doi: 10.1007/s00059-005-2732-3.
3
Inflammatory dilated cardiomyopathy (DCMI).炎症性扩张型心肌病(DCMI)。
Herz. 2005 Sep;30(6):535-44. doi: 10.1007/s00059-005-2730-5.
4
[How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].[扩张型心肌病的自然病史如何改变。的里雅斯特心肌病登记处综述]
Ital Heart J Suppl. 2004 Apr;5(4):253-66.
5
Genetics of dilated cardiomyopathy.扩张型心肌病的遗传学
Ann Med. 2007;39(2):91-107. doi: 10.1080/07853890601145821.
6
[The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].[扩张型心肌病的自然病史:的里雅斯特心肌疾病登记处综述]
Ital Heart J Suppl. 2004 Apr;5(4):253-66.
7
Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.105例非亲缘关系扩张型心肌病患者队列的临床及突变谱
Eur J Med Genet. 2011 Nov-Dec;54(6):e570-5. doi: 10.1016/j.ejmg.2011.07.005. Epub 2011 Aug 4.
8
Genetic ideology of dilated cardiompathy.扩张型心肌病的遗传学说
Isr Med Assoc J. 2005 Jun;7(6):392-6.
9
Familial dilated cardiomyopathy: evidence for clinical and immunogenetic heterogeneity.家族性扩张型心肌病:临床和免疫遗传学异质性的证据。
Med Sci Monit. 2003 May;9(5):CR167-74.
10
Portuguese study of familial dilated cardiomyopathy: the FATIMA study.葡萄牙家族性扩张型心肌病研究:法蒂玛研究
Rev Port Cardiol. 2008 Sep;27(9):1029-42.

引用本文的文献

1
Case report: A new mutation of the Troponin T2 gene in a Chinese patient with dilated cardiomyopathy.病例报告:一名中国扩张型心肌病患者肌钙蛋白T2基因的新突变。
Front Cardiovasc Med. 2023 Nov 20;10:1288328. doi: 10.3389/fcvm.2023.1288328. eCollection 2023.
2
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.肌联蛋白突变型扩张型心肌病诱导多能干细胞衍生心肌细胞的功能异常。
PLoS One. 2018 Oct 17;13(10):e0205719. doi: 10.1371/journal.pone.0205719. eCollection 2018.
3
in the Heart of Understanding Cardiac Diseases: Modeling Channelopathies and Cardiomyopathies in the Fruitfly.
深入了解心脏疾病的核心:在果蝇中模拟离子通道病和心肌病
J Cardiovasc Dev Dis. 2016 Feb 18;3(1):7. doi: 10.3390/jcdd3010007.
4
Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.人类诱导多能干细胞中与核纤层蛋白A/C相关的扩张型心肌病的治疗反应建模
J Am Heart Assoc. 2017 Jul 28;6(8):e005677. doi: 10.1161/JAHA.117.005677.
5
Screening first-degree relatives of patients with idiopathic dilated cardiomyopathy.对特发性扩张型心肌病患者的一级亲属进行筛查。
Herz. 2017 Nov;42(7):669-676. doi: 10.1007/s00059-016-4498-1. Epub 2016 Nov 10.
6
Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methods.通过生物信息学方法分析扩张型心肌病中的基因表达谱。
Braz J Med Biol Res. 2016 Oct 10;49(10):e4897. doi: 10.1590/1414-431X20164897.
7
Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.心脏核纤层病动物和人类多能干细胞建模的最新进展。
Stem Cell Res Ther. 2016 Sep 20;7(1):139. doi: 10.1186/s13287-016-0401-5.
8
Contextualizing Genetics for Regional Heart Failure Care.为区域心力衰竭护理将遗传学情境化。
Curr Cardiol Rev. 2016;12(3):231-42. doi: 10.2174/1573403x12666160606123103.
9
Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.家族性扩张型心肌病中钙稳态的药理学调节:来自RBM20患者来源的诱导多能干细胞模型的体外分析
Clin Transl Sci. 2016 Jun;9(3):158-67. doi: 10.1111/cts.12393. Epub 2016 Apr 22.
10
Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.利用人诱导多能干细胞模拟RBM20家族性扩张型心肌病的结构和功能缺陷。
Hum Mol Genet. 2016 Jan 15;25(2):254-65. doi: 10.1093/hmg/ddv468. Epub 2015 Nov 24.